Pacific Edge gains while market flatlines

Pacific Edge gains while market flatlines
Pacific Edge shares jumped after the Journal of Urology published a peer-reviewed study which found the use of the Cxbladder products was 4.8 times more efficient than the latest American Urology Association guidelines. (Image: Supplied)
Dan Brunskill
New Zealand’s benchmark equity index finished the day virtually unchanged, although cancer diagnostics firm Pacific Edge had a healthy bounce. The S&P/NZX 50 Index gained one single point, or 0.01%, to reach 12,752.51. Turnover was $194.5 million.Overnight, the US share market gained less than half a percent, although it is already in record territory while the NZX 50 is down 4.6% this year.The yield on US 10-year Treasuries dropped to its lowest level in more than four months, suggesting investors see inflation as less of a thre...